127 related articles for article (PubMed ID: 38910780)
41. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
Zwiech R; Adelt M; Chrul S
Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
[TBL] [Abstract][Full Text] [Related]
42. Mediastinal approach to the placement of tunneled hemodialysis catheters in patients with central vein occlusion in an outpatient access center.
Matsuura J; Dietrich A; Steuben S; Ricker J; Barkema K; Kuhl T
J Vasc Access; 2011; 12(3):258-61. PubMed ID: 21104666
[TBL] [Abstract][Full Text] [Related]
43. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
[TBL] [Abstract][Full Text] [Related]
44. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
45. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
46. Heparin Versus Normal Saline: Flushing Effectiveness in Managing Central Venous Catheters in Pediatric Patients With Cancer.
Omatsu D; Thompson K; Maglasang B; Yuasa H; Kimata C
Clin J Oncol Nurs; 2022 Jun; 26(3):300-307. PubMed ID: 35604736
[TBL] [Abstract][Full Text] [Related]
47. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
[TBL] [Abstract][Full Text] [Related]
48. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.
Silva TN; Mendes ML; Abrão JM; Caramori JT; Ponce D
Int Urol Nephrol; 2013 Oct; 45(5):1405-13. PubMed ID: 23269457
[TBL] [Abstract][Full Text] [Related]
49. Alteplase for the treatment of catheter occlusion in pediatric patients.
Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
[TBL] [Abstract][Full Text] [Related]
50. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
51. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
52. [Retrospective analysis of cuffed-tunneled catheters in pediatric patients receiving maintenance hemodialysis].
Wang P; Rao W; Sun LW; Wu Y; Chen WJ; Kang YL; Hao S; Zhu GH; Huang WY
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):657-661. PubMed ID: 30180403
[No Abstract] [Full Text] [Related]
53. Retrospective assessment of risk factors to predict tunneled hemodialysis catheter outcome.
Lee O; Raque JD; Lee LJ; Wivell W; Block CA; Bettmann MA
J Vasc Interv Radiol; 2004 May; 15(5):457-61. PubMed ID: 15126655
[TBL] [Abstract][Full Text] [Related]
54. The use of tissue plasminogen activator infusion to re-establish function of tunneled hemodialysis catheters.
Dowling K; Sansivero G; Stainken B; Siskin G; Dolen E; Ahn J; Mitchell N
Nephrol Nurs J; 2004; 31(2):199-200. PubMed ID: 15114800
[TBL] [Abstract][Full Text] [Related]
55. Use of a gentamicin-citrate lock leads to lower catheter-related bloodstream infection rates and reduced cost of care in hemodialysis patients.
Hussein WF; Gomez N; Sun SJ; Yu J; Yang F; Ajuria M; Abra GE; Schiller B
Hemodial Int; 2021 Jan; 25(1):20-28. PubMed ID: 33006269
[TBL] [Abstract][Full Text] [Related]
56. An economic evaluation of rt-PA locking solution in dialysis catheters.
Manns BJ; Scott-Douglas N; Tonelli M; Ravani P; LeBlanc M; Dorval M; Holden R; Moist L; Lok C; Zimmerman D; Au F; Hemmelgarn BR
J Am Soc Nephrol; 2014 Dec; 25(12):2887-95. PubMed ID: 25012176
[TBL] [Abstract][Full Text] [Related]
57. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
[TBL] [Abstract][Full Text] [Related]
58. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime.
Mortazavi M; Alsaeidi S; Sobhani R; Salimi F; Atapour A; Sharif N; Akbari M; Pakzad B; Jazi AH
J Res Med Sci; 2011 Mar; 16(3):303-9. PubMed ID: 22091249
[TBL] [Abstract][Full Text] [Related]
59. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
[TBL] [Abstract][Full Text] [Related]
60. Does heparin coating improve patency or reduce infection of tunneled dialysis catheters?
Jain G; Allon M; Saddekni S; Barker JF; Maya ID
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1787-90. PubMed ID: 19729425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
